text:
Brockville, Ont. plant wins performance award
January 22, 2013 by CanadianManufacturing.com Staff
Award given to North American plant that achieves the highest cumulative score on key performance metrics
Exelon wins 'Strategic Deal of the Year' for March merger
December 3, 2012 by CanadianManufacturing.com Staff
The award recognizes the success of a new energy project, asset buyout, merger or acquisition in a time of uncertain markets and global interdependence.
HSBC announces International Business of the Year finalists
April 12, 2011 by Canadian Manufacturing Daily Staff
Awards highlight Canada's best SMEs doing business internationally
Celebrating Ontario's top innovators
March 25, 2010 by Noelle Stapinsky
Each year the Premier's Innovation Awards—part of Ontario's Innovation Agenda—invests $200,000 to $5 million in the provinces top innovators to help advance their cutting-edge research and development, while boosting global competitiveness and creating more high-skilled jobs. This year's awards ceremony,…


Founded in 2011, Phantom Intelligence protects vulnerable road users (VRUs) and improves the safety and fluidity of travel by offering solutions that enable reliable advanced driver-assistance systems (ADAS) that are affordable. Our unique digital signal processing approach to LiDAR is at the heart of devices that can be trusted where other sensors fail. This approach enables you to achieve your reliable, affordable LiDAR objectives, today.
Phantom Intelligence LiDAR digital signal processing is multilayered, enabling more processing at the edge, taking care of everything from acquisition to threat assessment.
Phantom Intelligence algorithms easily adjust to FPGAs, GPUs, and DSPs, depending on your needs. The configurable acquisition layer is also easy to adapt to multiple LiDAR architectures.
Supporting this mission, our dynamic team works tirelessly to develop, improve, and share our flash LiDAR technology.
Jean-Yves Deschênes was product director for many successful startup businesses and public corporations focused on innovation. He is an expert in integrated systems and has many years of experience in developing technology solutions for the military and industrial sectors.
Éric Turenne is an expert in high-speed digital signal processing applied to LiDAR systems. Following his graduate studies, he worked for various high-tech companies and designed complex electronic systems. He founded Phantom Intelligence in 2011. Éric holds an MBA and a B.Sc. in electrical engineering from Université Laval.


The next AAIP meeting will be at Maggiano's Little Italy 4400 Ashford Dunwoody Road, Dunwoody, GA 30346 with registration beginning at 6:00 pm.
The CE portion of the meeting "Chemotherapy Extravasation", will be presented by Huong Pham, PharmD.
The CE slides will be emailed to members on the RSVP list prior to the meeting.
The next AAIP meeting will take place on Thursday, January 17th at Atlanta Fish Market, 265 Pharr Rd NE, Atlanta, GA 30305 with registration beginning at 6:00 pm.
The CE program will be "Summary of the 2016 SCCM/ASPEN Guidelines for Nutrition Support in the Critically Ill" will be presented by Adina Hirsch, PharmD, BCNSP.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. To RSVP please use the link provided below.
The next AAIP meeting will take place on Thursday, November 8th at 103 West, 103 West Paces Ferry Rd NW, Atlanta, GA 30305 at 6:30 pm.
"Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)" will be presented by Alan K. Jacobson, MD, FACC. Dr. Jacobson is paid speaker for Portola Pharmaceutical.
The CE program will follow. "Medication Safety" will be presented by Drew Stivers, PharmD, Manager for Medication Use and Safety, Emory University Hospital Midtown.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. To RSVP please use the link provided below. Please note Sarah Joel (Sjoel@portola.com) from Portola is taking RSVPs for this meeting.
The next AAIP meeting will take place on Thursday, October 25th at Maggiano's Little Italy, 4400 Ashford-Dunwoody Rd Atlanta, GA 30346.
Registration will begin at 6:15pm, followed by the presentations and dinner at 6:45pm.
"Review of a Prophylactic Approach Cytomegalovirus" will be presented by Justin LaPorte, PharmD, BCOP. Dr. LaPorte is a paid speaker for Merck & Co., Inc.
The CE program will follow. "An Introduction to Specialty Pharmacy" will be presented by Lisa Aquillano, PharmD, BCPS, Pharmacist Specialist. Slides of the CE presentation will be sent out to attendees closer to the meeting.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members.
"Updated Considerations for Management of Clostridium difficile: A Case-Based Discussion" will be presented by Andrew B. Dold, DO. Dr. Dold is a paid speaker for Merck & Co., Inc.
The CE program will follow. "Push it! The art of getting it out: Therapies for neurogenic bladder and bowel" will be presented by Caitlin Stehling, PharmD, Pharmacist Specialist at Children's Healthcare of Atlanta. Slides of the CE presentation will be sent out closer to the meeting.
Registration will begin at 6:00pm, followed by the presentations and dinner at 6:30pm.
click here for the CE handout.
Our next meeting will be Thursday, August 16, 2018 at Davios Northern Italian Steakhouse located in Phipps Plaza at 3500 Peachtree Rd. NE, Atlanta, GA 30326 (404-844-4810).
Registration will begin at 6:30pm, followed by the presentation and dinner at 7:00pm.
"When Every Moment Counts: Appropriate Treatment Options for MRSA or MSSA Infections" will be presented by Adam Bressler, MD, Medical Director Infectious Disease Specialists of Atlanta. Dr. Bressler is a paid speaker for Theravance.
There will not be a CE portion of this program.
"Myth or Reality: The Rabies Threat in the US and the Role of Postexposure Prophylaxis" will be presented by Charles E. Rupprecht VMD, MS, PhD. Dr Rupprecht is a paid speaker for Grifols.
The CE program will follow. "Biosimilars: Surfacin' in the US" will be presented by Jessica C. Gorgeis, PharmD, Clinical BMT Pharmacist, Northside Hospital.
We look forward to seeing you on Thursday, June 21st!
To RSVP please use the link provided below.
The Atlanta Academy of Institutional Pharmacy (AAIP) invites you to join us for the 2018 Annual Awards Banquet! The Exhibitor Showcase, installation of officers, and awards ceremony will be held on Thursday, May 17, 2018 at Ansley Golf Club located at 196 Montgomery Ferry Drive NE, Atlanta, GA 30309.
Registration will begin at 5:30 pm with the Exhibitor Showcase, a tabletop exhibit hosted by notable, pharmaceutical companies and representatives. The showcase will provide AAIP members with applicable education and informative displays on various drug products. We encourage you to come early and enjoy the Exhibitors' Showcase! Following the exhibit, the Banquet Dinner, installation of officers and CE presentations will begin at 7:00 pm.
"Pharmacist impact on pain prescribing and control in hospitalized patients" by Eryn Thacker, PharmD, PGY1 Pharmacy Resident, Northside Hospital.
"Impact of BioFire FilmArray gastrointestinal panel on antimicrobial management of adults presenting with acute gastroenteritis" by Natalie Morgan, PharmD, PGY1 Pharmacy Resident, Piedmont Hospital.
"Outcomes of bacteremia caused by inducible AmpC beta-lactamase producing Enterobacteriaceae treated with piperacillin-tazobactam" by Lisa Sagardia, PharmD, PGY 1 Pharmacy Resident, Emory University Hospital Midtown.
"Vancomycin versus linezolid for treatment of MSRA pulmonary exacerbations in hospitalized pediatric cystic fibrosis patients" by Ali Ward, PharmD, PGY 1 Pharmacy Resident, Children's Healthcare of Atlanta.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. One hour (0.1CEU) is provided with this meeting.
If you would like to attend this meeting, click on the RSVP link!
The next meeting of Atlanta Academy of Institutional Pharmacy will be held on Thursday, April 26, 2018, at the Davio's Northern Italian Steakhouse, located at Phipps Plaza, 3500 Peachtree Road NE Atlanta, GA 30326. Registration will begin at 6:00 pm, followed by dinner and presentations at 6:30 pm.
"A Breakthrough in Cardiovascular Outcomes: Jardiance® CV Outcome Study" will be presented by Bruce Bode, MD, FACE, a Clinical Associate Professor in the Department of Medicine at Emory University School of Medicine. This is a promotional talk sponsored by Erin Sadler, a pharmaceutical representative for Boehringer Ingelheim, Inc.
Following Dr. Bode's presentation, Rosemary P Cross, PharmD, BCPS, a Transplant Clinical Pharmacist at Piedmont Transplant Institute, will present "Hepatitis C – A Star Wars Saga" for one hour of continuing education (0.1 CEU).
If you would like to reserve a seat for this meeting, please visit the RSVP page!
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. One hour of continuing education credit is provided with this meeting.
The next meeting of Atlanta Academy of Institutional Pharmacy will be held on Tuesday, March 13, 2018, at the Maggiano's Little Italy, located at 4400 Ashford Dunwoody Road (at Perimeter Mall) Atlanta, GA 30346.
Registration will begin at 6 pm, followed by dinner at 6:30 pm. This is a promotional talk funded in part by Janssen Pharmaceuticals, Inc. "Xarelto Pivotal Trials and Recently Published Real-World Evidence in NVAF and DVT/PE" will be presented by Narendra Singh, MD, Clinical Assistant Professor/Director of Clinical Research at Medical College of Georgia in August, GA. Dr. Singh is a paid speaker for Janssen Pharmaceutical, Inc. The meeting announcement is attached.
Following Dr. Sing's presentation, Reno Law, PharmD, Critical Care pharmacist at Northside Hospital, will give a talk for one hour of continuing education (0.1CEU).
The next meeting of Atlanta Academy of Institutional Pharmacy will be held on Thursday, February 22, 2018, at the Atlanta Fish Market, located at 265 Pharr Road in Buckhead, Atlanta, 30305.
Registration will begin at 6:30pm, followed by dinner at 7pm. This is a promotional talk funded in part by Astellas Pharma US, Inc. No CE is provided. Astellas has asked that only those who provide direct patient care attend the meeting. Per Astellas: "pharmaceutical company employees even though they are members of AAIP are not part of the direct patient healthcare decision making team and therefore are not appropriate to attend this promotional program". Additionally, Astellas recognizes that VA employees are restricted by VA policy from taking the meal.
"Understanding the Impact of Invasive Fungal Infections: Candidemia, Invasive Aspergillosis, and Invasive Mucormycosis", will be presented by Andrew Dold, DO, Infectious Disease Consultants in Suwanee. Dr. Dold is a paid speaker for Astellas Pharma US, Inc.
As you know, attendance to this and all AAIP meetings are restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. No continuing education credits are provided with this meeting.
The next meeting of Atlanta Academy of Institutional Pharmacy will be held on Thursday, February 1, 2018, at Maggiano's Little Italy in Buckhead, located at 3368 Peachtree Road in Buckhead, Atlanta, 30326 (770-730-8447).
Registration will begin at 6:30pm, followed by the presentation and dinner at 7pm.
"Hazardous Drug Handling and Adopting USP 800" will be presented by Fred Massoomi, PharmD, FASHP, Senior Director at Visante, Inc. Dr. Massoomi is a paid speaker for Salveo Healthcare.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. No continuing education is provided with this meeting.
The next meeting of Atlanta Academy of Institutional Pharmacy will be held on Thursday, January 18, 2018, at 103 West Restaurant, located at 103 West Paces Ferry Road in Buckhead, Atlanta, 30305.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. There will be 2 presentations for the evening. The Daiichi Sankyo, Inc. presentation will begin at 6:30pm with Dr. Bhimani's presentation and dinner. Following Dr. Bhimani's talk, we will have the presentation for continuing education credits.
"Hematologists/Oncologists' roles for recognizing and treating iron deficiency anemia", will be presented by Chandar Bhimani, MD, Dekalb Medical Physicians Group Atlanta Oncology Specialists in Decatur. Dr. Bhimani is a paid speaker for Daiichi Sankyo, Inc.
"Common parasites and treatment modalities in dogs and cats" will be presented by Heather Lindell, PharmD, BSPh, RPh, DICVP, FSVHP, Assistant Director of University of Georgia Teaching Hospital for the University of Georgia College of Veterinary Medicine in Athens, Ga; and Spencer Tally, PharmD, DVM, Medical Director of Per Vet Clinic in Cartersville, Ga. One hour of continuing education is provided with Dr. Lindell's and Tally's presentation.
Please click HERE to obtain the presentation powerpoint slides for this meeting!
Registration will begin at 6:00pm, followed by dinner at 6:30pm. There will be 2 presentations for the evening. The Otsuka Pharmaceutical presentation will begin at 6:30pm with dinner, followed by Dr. Christensen's presentation for CE.
"Hyponatremia in Heart Failure and Hyponatremia in SIADH", will be presented by Janssen Sacro, PharmD, Citrus Valley Health Partners in Covina, Ca. Dr. Sacro is a paid speaker for Otsuka America Pharmaceuticals.
"Every Story Has Two Sides: Vasopressin Agonists and Antagonist in Hyponatremia" will be presented by Erin Christensen, PharmD, BCPS, Clinical Pharmacist II Critical Care, at Emory University Hospital Midtown in Atlanta. One hour of continuing education is provided with Dr. Christensen's presentation.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. One hour of continuing education (0.1 CEU) is provided with this meeting.
Registration will begin at 6:30pm, followed by dinner at 7:00pm.
"In-Hospital to Home: New Standards for Extended Duration VTE Prophylaxis in Acutely Ill Medical Patients" will be presented by Diane Wirth, MS, ANP-BC, CACP, at Grady Memorial Hospital in Atlanta. Ms. Wirth is a paid speaker for Portola Pharmaceuticals.
If you would like to reserve a seat for this meeting, please go to www.hlxregister.com. The reference program code is XM7R2P. The flyer for the program is available to download below.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. No continuing education credits are provided with this meeting.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. There will be 2 presentations for the evening. The Allergan presentation will begin at 6:30pm with dinner, followed by the CE presentation.
"Avycaz: It's use in clinical practice" will be presented by Danny Branstetterr, MD, Infectious Diseases at WellStar Kennestone Hospital in Atlanta. Dr. Branstetter is a paid speaker for Allergan Pharmaceuticals.
"Meeting the Joint Commission's new antimicrobial stewardship standard" will be presented by Joy Peterson, PharmD, BCPS, Clinical Pharmacist in Infectious Diseases at WellStar Kenneston Hospital in Atlanta. One hour of continuing education is provided with Dr. Peterson's presentation.
"Immune Globulin Characteristics and Clinical Considerations of Treatment" is one of the Immune Globulin Stewardship Series of programs hosted by Shire Pharmaceuticals. The program will be presented by Jerry Siegel, Clinical Associate Professor at Ohio State University in Columbus, Ohio. Dr. Siegel is a paid speaker for Shire Pharmaceuticals.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. There will be 2 presentations for the evening. The Salix presentation will begin at 6:30pm with dinner, followed by Dr. Champion's presentation for CE.
"Reducing the burden of cirrhosis and hepatic encephalopathy", will be presented by Roshan Shrestha, MD, Medical Director of Liver Transplantation at Piedmont Hospital in Atlanta. Dr. Shrestha is a paid speaker for Salix Pharmaceuticals.
"Current Issues in Immunizations" will be presented by Caroline Champion, PharmD, Assistant Professor of Pharmacy Practice, Philadelphia College of Osteopathic Medicine, School of Pharmacy in Atlanta. One hour of continuing education is provided with Dr. Champion's presentation.
Registration will begin at 6:00pm, followed by dinner at 6:30 pm.
"Insights on Novel Technology in Pain Management with Abuse Deterrent Extended-Release Opioids" will be presented by Bruce Friedman, MD, Critical Care Co-Director of JM Still Burn Center, Professor of Medicine, Anesthiology and Perioperative Medicine in Augusta, Ga.
The next presentation, "The Steps on "OUCH!" Acute Pain Pathophysiology and Treatment" will be presented by Kimm Freeman, PharmD, BCPS, CPE at WellStar Cobb Hospital in Atlanta.
Collegium has asked that no other pharmaceutical representative attend the program.
Upon reserving a seat at the meeting, you will receive a confirmation message. Space is limited. This meeting has a promotional presentation, as well as providing one hour (0.1CEU) of continuing education credit. This meeting is funded in part by Collegium Pharmaceuticals.
Annual banquet, installation of officers, and annual awards will be presented. Registration will begin at 5:30pm with the annual Exhibitors' Showcase. We will host drug company representatives displaying information on their products. We encourage you to come early to enjoy the Exhibitors' Showcase.
Dinner, installation of officers and presentations will begin at 7:00 pm.
After your RSVP is processed, you will receive a confirmation email. As you know, attendance to this and all AAIP meetings is restricted to members only. This meeting is provided at no charge to members. Space is limited. The program provides one hour of continuing education (0.1 CEU).
Any grievance related to administration of this program will be at the sole discretion of the AAIP Board of Directors.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. There will be 2 presentations for the evening. The BTG International presentation will begin at 6:30pm with dinner, followed by Dr. Lee's presentation for CE.
"The Hidden Population: Patients with 5-FU or Capecitibine Early-Onset, Severe Toxicity", will be presented by Amber Draper, PharmD, BCOP, Clinical Pharmacist for Emory Winship Infusion Centers in Atlanta. Dr. Draper is a paid speaker for BTG International, Inc.
"Investigating the Benefit versus Cost of IV Acetaminophen in the Perioperative Setting" will be presented by Collin Lee, PharmD, BCPS, Assistant Director for Clinical and Educational Services of Emory Healthcare, Department of Pharmacy in Atlanta. One hour of continuing education is provided with Dr. Lee's presentation.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. One hour of continuing education (0.1 CEU) is provided with this meeting.
Registration will begin at 6:00pm, followed by dinner at 6:30pm.
"A Pan Tumor Opdivo Update" will be presented by Mohamed Omar, RPh, PhD. Dr. Omar is a paid speaker for Bristol –Myers Squibb.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. This is a promotional meeting. No continuing education credits are provided with this meeting.
Registration will begin at 6:30pm, followed by dinner at 7:00pm. There will be 2 presentations for the evening. Janssen Pharmaceuticals presentation will begin at 7:00pm with dinner, followed by Dr. Paciullo's presentation for CE.
"Xarelto Pivotal Trials and Recently Published Real World Evidence in DVT/PE", will be presented by Diane Wirth, NP, Clinical Manager Heart Failure Program at Grady Memorial Hospital in Atlanta. Ms. Wirth is a paid speaker for Janssen Pharmaceuticals, Inc.
"De-mystifying Ketamine" will be presented by Chris Paciullo, PharmD, BCCCP, FCCM, Pharmacy Manager, Emory University Hospital Midtown in Atlanta. One hour of continuing education is provided with Dr. Paciullo's presentation.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. Note that the start time is 6 pm (30 minutes earlier than usual). There will be 2 presentations for the evening. Theravance presentation will begin at 6:30pm with dinner, followed by Dr. Carroll's presentation for CE.
"Treatment options for adult patients with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia" will be presented by Mobolaji Ogunsakin, MD, Infections Specialists of Middle Georgia, Navicent Health, Macon, Ga.
"What's pneu with Pneumonia? IDSA Guideline Update" will be presented by Victoria Carroll, PharmD, BCPS, Infectious Disease Clinical Pharmacist at Northside Hospital in Atlanta.
PROGRAM GOAL: The goal of this knowledge-based activity is to review the updated 2016 IDSA guidelines on the management of hospital-acquired (HAP) and ventilator-associated (VAP) pneumonia.
The Atlanta Academy of Institutional Pharmacists is an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. This program is supported in part by Theravance Biopharma.
Registration will begin at 6:00pm, followed by dinner at 6:30pm. Note that this time is 30 minutes earlier than our usual registration time.
An Evidence-Based Approach to Support the Role of Avastin in the Treatment of First-Through Second-line Metastatic Colorectal Cancer (mCRC) will be presented by Ki Chung, MD, Associate Professor of Medicine for the Greenville Health System Cancer Institute/ITOR, in Spartanburg, SC.
This is a promotional talk sponsored by Laura Freeman of Genentech. Attached is the meeting program. No CE associated with this program.
As you know, attendance to this and all AAIP meetings is restricted to members only. Attendance is limited. This meeting is provided at no charge to members. Space is limited. No CE is provided with this meeting. Any grievance related to administration of this program will be at the sole discretion of the AAIP Board of Directors.


text:
Identifying Patients with Persistent Preventable Utilization Offers an Opportunity to Reduce Unnecessary Spending
In a new study published in the Journal of General Internal Medicine, researchers from the Department of Population Health Sciences identified patients with persistent preventable utilization to compare their characteristics with high-cost patients. Together, Rainu Kaushal, MD, MPH, senior associate dean for clinical research, chair of the Department of Population Health Sciences and Nanette Laitman Distinguished Professor of Population Health Sciences; Yongkang Zhang, PhD, research associate in population health sciences; Dhruv Khullar, MD, MPP, assistant professor of population health sciences; Yiyuan Wu, research biostatistician in population health sciences; and Lawrence Casalino, MD, MPH, professor of population health sciences, compared demographic, medical, behavioral, and social characteristics and total and preventable healthcare utilization between the two patient groups. They found that patients with persistent preventable utilization had lower median healthcare costs ($33,383 vs. $56,552) than high-cost patients, but their median potentially preventable costs were seven times higher ($7151 vs. $928). Overall, the researchers suggest that interventions designed for and targeted towards patients with persistent preventable utilization could be a way to reduce unnecessary utilization while promoting high-value care.

redpajama_set_name: RedPajamaCommonCrawl


text:
Google releases Anthos for cloud management
Google has released the production version of its Anthos platform for managing multicloud applications.
Formerly known as Google Cloud Services Platform, Anthos is a Kubernetes-powered technology to build and manage hybrid applications, for on-premises or cloud deployments. Anthos is available on Google Cloud Platform with Google Kubernetes Engine (GKE), adding infrastructure around Kubernetes.
[ InfoWorld explains: What is multicloud? The next step in cloud computing. | Get started: Going multicloud? Avoid these 3 pitfalls. • Understand the multicloud management trade-off. | Keep up with the latest developments in cloud computing with InfoWorld's Cloud Computing newsletter. ]
Anthos also can manage workloads on third-party clouds, including Amazon Web Services and Microsoft Azure. With Anthos, IT resources are put into a consistent framework for management, development, and control, with low-value and insecure tasks automated across on-premise sand Google Cloud infrastructure.
Features in Anthos include:
Jobs can be written once and run anywhere, including Google's cloud, other clouds or the user's data center.
Users can run Anthos on existing hardware with no forced stack refresh.
APIs are provided for users to work with Anthos at their own pace.
Linkage to GKE means users get the most-recent feature updates and security patches.
Aside from Kubernetes, Anthos also is built on Istio, which is an open source service mesh to reduce the complexity of cloud deployments, and Knative, a Kubernetes platform for managing serverless workloads.
As part of the Anthos rollout, Google introduced a beta version of Anthos Migrate, to automigrate virtual machines from on-premises or other clouds to to containers in GKE. It handles infrastructure tasks such as OS patching and VM maintenance.
To get started with Anthos, users must set up a GKE On-Prem Cluster and start running new cloud-native apps or migrate some existing applications into a cluster. The cluster then must be registered with GKE. Users have the option to install Istio on GKE clusters to create service meshes. Also, Anthos Config Management must be enabled across GKE clusters.